(Q39125495)

9 September 2017

title

Expression and significance of miRNA-21 and BTG2 in lung cancer (English)

1 reference

9 September 2017

Qing Sun

1

1 reference

9 September 2017

Meng Hang

2

1 reference

9 September 2017

Xuedan Guo

3

1 reference

9 September 2017

Wenlong Shao

4

1 reference

9 September 2017

Guangqiao Zeng

5

1 reference

9 September 2017

publication date

16 July 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

34

1 reference

9 September 2017

issue

6

1 reference

9 September 2017

page(s)

4017-4026

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-0992-8

9 September 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

DNA damage induces NF-κB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

MicroRNAs control hepatocyte proliferation during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

The mammalian anti-proliferative BTG/Tob protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Roles for microRNAs in conferring robustness to biological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Clinical outcome prediction by microRNAs in human cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

MicroRNA, nutrition, and cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Identification of novel genes coding for small expressed RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Biosynthesis of docosahexaenoic acid in Euglena gracilis: biochemical and molecular evidence for the involvement of a Delta4-fatty acyl group desaturase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0992-8

Biomarkers and prognostic factors for mesothelioma

21 January 2018

1 reference

12 December 2020

Circulating tumor-derived biomarkers in lung cancer

1 reference

12 December 2020

MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship

1 reference

12 December 2020

Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib

1 reference

12 December 2020

microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN

1 reference

12 December 2020

Dulanermin in cancer therapy: still much to do.

1 reference

12 December 2020

The efficacy of the inhalation of an aerosolized Group A streptococcal preparation in the treatment of lung cancer

1 reference

12 December 2020

Clinical significance of the tumor microenvironment in non-small cell lung cancer

1 reference

12 December 2020

BTG2, its family and its tutor.

1 reference

12 December 2020

10.1007/S13277-013-0992-8

Identifiers

DOI

1 reference

9 September 2017

1 reference